Internal Server Error

About Invoke Capital

Invoke Capital is a venture capital firm founded in 2012. It is primarily based out of London, United Kingdom. As of Feb 2019, Invoke Capital has invested in 6 companies. It primarily invests in Series A round in United Kingdom based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to High Tech and Enterprise Infrastructure. Most recently it participated in the $***** Series B round of Luminance Overall, Invoke Capital portfolio has seen 1 IPO and 2 acquisitions, namely Darktrace, Featurespace and Sophia Genetics. A lot of funds co-invest with Invoke Capital, with names like Slaughter and May sharing a substantial percentage of its portfolio. Invoke Capital has team of 1 people including 1 partners.
Key Metrics
Team Members
Portfolio Count
Portfolio Locations
Rounds of Entry
Seed, Series A & 2 more
Portfolio IPOs
Portfolio Acquisitions

Invoke Capital's List of Top Investments

Invoke Capital has a portfolio of 6 companies. Their most notable investments are in Sophia Genetics and Luminance.Their portfolio spans across United Kingdom and Switzerland. They have invested in Enterprise Applications, High Tech, Enterprise Infrastructure and 2 other sectors, across stages such as Seed, Series A  and 2 more. Here is the list of top investments by Invoke Capital:
Developer of artificial intelligence software for enterprise cybersecurity threat detection. This technology monitors network, email, cloud, and endpoint environments to identify anomalous activity. It utilizes machine learning to establish patterns of normal behavior across digital infrastructures. By analyzing deviations from these established baselines, the software detects and responds to potential security incidents. The system integrates with existing infrastructure to provide visibility into various attack vectors, including ransomware, phishing, and insider threats. It automates the triage of security alerts to assist in the identification of malicious activity. The platform supports the protection of converged information technology and operational technology environments.

Key facts about Darktrace

AI based platform for contract analytics and due diligence. The platform uses AI to automatically read and understand hundreds of pages of complex legal documentation. It helps in identifying potential risks in the data room, uncovering anomalies or even missing data, and in prioritizing review and allocation of tasks. Core features include clause identification, data visualizer, and anomaly detection. It has been trained by legal experts to accurately identify and label documents, clauses, people, places, and language, and not just keyword search.

Key facts about Luminance

Developer of risk management and fraud prevention software solutions. The company provides a platform designed to model and predict individual behavior in real time. This platform is used for fraud prevention and anti-money laundering purposes. It allows computers to understand when an individual customer’s behavior is out of character. The platform evaluates risk automatically.

Key facts about Featurespace

AI-driven platform for clinicians to generate real-time insights for patients with cancer and rare disorders. The platform uses machine learning algorithms to process and analyze genomic data from patient DNA sequence data generated from the NGS platform. The company's products like Radiomics assist with precision medicine diagnosis and medical imaging for oncology disease detection. Another product of the company Sophia DDM has features for data organization, drug development, and domain modeling.

Key facts about Sophia Genetics

Key facts about Neurence

  • Founded Year: 2012
  • Location: Cambridge (United Kingdom)
  • Stage: Series A
  • Total Funding till date: $4M
  • Employee Count: 2 as on Jun 30, 2025
  • Investors: Invoke Capital
  • Latest Funding Round: Series A, Dec 03, 2013, $*****

Invoke Capital's Investments by Stage

Invoke Capital has made 2 investments in Seed stage, 2 investments in Series A stage with an average round size of $3.5M, 1 investment in Series B stage with an average round size of $13.8M and 1 investment in Series C stage with an average round size of $21.9M.
Here are Invoke Capital's investments by stage:
Stage of entry
No. of Investments
Seed
2
Series A
2
Series B
1
Series C
1
Breakdown of Invoke Capital's investments by stage of entrySeed (2)Series A (2)
Note: We have considered here, only first round of investments

Invoke Capital's Investments by Sector

Invoke Capital has a diverse portfolio, with companies operating in the Enterprise Applications, Artificial Intelligence - Industry Applications, Enterprise Infrastructure, Vertical SaaS and FinTech. Notably, it has invested in 5 Enterprise (B2B) companies, 5 Tech companies, 4 Saas companies and at least 4 companies focusing on Software.
Here are Invoke Capital's investments by sector:
Sector
No. of Investments
Enterprise Applications
4
Artificial Intelligence - Industry Applications
2
Enterprise Infrastructure
2
Vertical SaaS
2
FinTech
1
Others
2
Breakdown of Invoke Capital's investments by sectorsEnterprise Applic... (4)Artificial Intell... (2)
Note: We have considered here, only first round of investments

Invoke Capital's Investments by Geography

Invoke Capital has made most investments in United Kingdom (5), followed by Switzerland where it has made 1 investment.
Here are Invoke Capital's investments by geography:
Country
No. of Investments
United Kingdom
5
Switzerland
1
Breakdown of Invoke Capital's investments by countriesUnited Kingdom (5)Switzerland (1)
Note: We have considered here, only first round of investments

Invoke Capital's recent investments

Invoke Capital has not made any investment in 2026 so far.
Here are the most recent investments by Invoke Capital:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Feb 07, 2019
United Kingdom
Series B
1114
Jan 25, 2019
United Kingdom
Series D
9155
Nov 29, 2017
United Kingdom
Series A
3140
Sep 13, 2017
Switzerland
Series D
5621
Aug 01, 2017
United Kingdom
Series C
7740

IPOs and Publicly Listed companies in Invoke Capital's Portfolio

1 of Invoke Capital's portfolio company became public -  Sophia Genetics. It got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jul 2021 at marketcap of $1.14B
Here are Invoke Capital's portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Jul 23, 2021
Jul 08, 2014
Series B
8869

Acquired companies in Invoke Capital's Portfolio

2 companies from Invoke Capital's portfolio have been acquired. The most recent acquisition was Featurespace in Sep 2024 by Visa for $*****.
Here are Invoke Capital's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Sep 26, 2024
Aug 01, 2017
Series C
6813
Apr 26, 2024
Sep 16, 2013
Seed
5254

Team profile of Invoke Capital

Invoke Capital has a team of 1 member located in United Kingdom. Invoke Capital's team does not sit on the board of any company as of now.

Co-investors of Invoke Capital

Over the past 13 years, 49 investors have co-invested in Invoke Capital's portfolio companies. This includes funds and angels.

  • Invested before Invoke CapitalTTV Capital, Nesta Impact Investments and 5 others have invested in rounds before Invoke Capital. There is 1 company where TTV Capital has invested before Invoke Capital and 1 company where Nesta Impact Investments has invested before Invoke Capital.
  • Top Co-investors of Invoke Capital7 investors entered a company along with Invoke Capital. These include investors like Slaughter and May (1 company).
  • Invested after Invoke CapitalA total of 35 investors have invested in Invoke Capital's portfolio after their investments. Top Investors include Insight Partners (2 companies), Talis Capital (2 companies) and Summit Partners (1 company).

Recent News related to Invoke Capital

View all news related to Invoke Capital

FAQs about Invoke Capital

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford